“cytomx-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC 03/24/17 National
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More 01/22/16 San Francisco
West Coast Biotech Roundup: KaloBios, Atreca, Acadia, Twist & More 11/06/15 San Francisco
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO 10/08/15 San Francisco
CytomX Therapeutics Receives $80,000,000 New Funding 10/08/15 San Francisco
Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round 09/08/15 Boston
West Coast Biotech Roundup: Amgen, Grizzlies, Topol, Faraday & More 09/03/15 San Francisco
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
CytomX Therapeutics Receives $70,000,000 Series D Financing 06/17/15 San Francisco
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
CytomX Therapeutics Receives $20,000,000 Series C Financing 01/06/15 San Francisco
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
CytomX Therapeutics Adds $11M For Antibody Drugs 07/31/12 San Francisco
CytomX Therapeutics Lands $31,000,000 Series B Financing 07/31/12 San Francisco
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies 10/11/11 San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Page 1 of 2 next page »